Trial intelligence / Profile preview

Field study of intradermal Intanza influenza vaccination in adults aged 60 years and older

2009-014637-24Phase 2Completed

Sponsor
IRCCS Ospedale Policlinico San Martino
Start
Aug 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of IDflu in influenza, sponsored by IRCCS Ospedale Policlinico San Martino. Primary endpoints: Safety and tolerability of Intanza, Immunogenicity and 2 more. Started Aug 2009; status: completed.

02

Drugs

IDflu
03

Conditions

influenza

Beyond the preview

Go deeper on 2009-014637-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014637-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call